Scientists at the University of Kansas Medical Center just published the first-ever human trial of creatine in Alzheimer's patients — and the results are striking. Brain creatine levels rose by 11%, working memory improved, and executive function showed near-significant gains, all in just 8 weeks. If you're over 40 and haven't been paying attention to what creatine does inside your brain, now is the time to start.
The study, formally called the Creatine to Augment Bioenergetics in Alzheimer's (CABA) trial, was published in Alzheimer's & Dementia: Translational Research & Clinical Interventions in 2025. It didn't make headlines the way it should have. But the findings matter — not just for people already diagnosed, but for every adult over 40 who cares about what happens to their brain in the next 20 years.
Why Alzheimer's Is Fundamentally an Energy Problem — And Why Creatine Addresses It at the Source
Here's what most coverage of Alzheimer's gets wrong: the disease isn't only about amyloid plaques and tau tangles. At its core, Alzheimer's is an energy crisis in the brain.
Brain cells — neurons — are among the most energy-hungry cells in the body. They depend on a constant, uninterrupted supply of ATP (adenosine triphosphate) to fire signals, consolidate memories, and maintain synaptic connections. In Alzheimer's disease, mitochondria in brain cells lose their ability to produce ATP efficiently. The brain's energy supply starts failing years — sometimes decades — before cognitive symptoms appear.
This is where creatine comes in. Creatine's primary role in the body is not building muscle — it's managing energy. Inside cells, creatine is stored as phosphocreatine (PCr), a high-energy molecule that acts as a rapid-response energy reserve. When a cell suddenly needs ATP, phosphocreatine donates a phosphate group to regenerate it almost instantly. Think of it as the body's emergency power generator.
The brain uses this phosphocreatine system just like muscles do. And here's the critical finding from the CABA study: in 19 participants with Alzheimer's disease, 8 weeks of creatine monohydrate supplementation increased brain creatine levels by 11%, as confirmed by magnetic resonance spectroscopy — a brain imaging technique that can actually measure creatine concentrations in living tissue.
That's not a small finding. It's the first direct human evidence that you can measurably increase brain energy reserves in people with Alzheimer's disease using a safe, inexpensive, over-the-counter supplement.
The Specific Cognitive Improvements Found — And What They Tell Us About Prevention
The CABA researchers used the NIH Toolbox Cognition Battery to measure cognitive changes before and after the 8-week creatine intervention. Two domains showed meaningful improvement:
Working memory — the type of short-term memory you use to hold information in mind while doing something else (remembering a phone number while dialing, following multi-step instructions, tracking a conversation). This is often one of the first cognitive functions to decline in early Alzheimer's.
Executive function — your ability to focus, filter distractions, plan, and shift between tasks. The study found what lead researcher Matthew Taylor, Ph.D., called a "nearly statistically significant improvement" — meaningful given the small sample size and 8-week window.
Taylor was careful to note the limitations: no control group, only 19 participants, and a relatively short intervention period. But he was direct about the implications: "These preliminary results suggest that there are good things happening here, that creatine has a benefit. This is a great rationale for doing more clinical trials with larger sample sizes."
What makes these findings relevant to healthy adults over 40 is the timing. The brain energy deficits that characterize Alzheimer's don't appear suddenly at diagnosis — they accumulate over decades. Research shows that by the time cognitive symptoms appear, significant neuronal damage has already occurred. The logic of early intervention is straightforward: if creatine can replenish brain energy reserves in people who already have Alzheimer's, it may help protect those reserves in people whose brains are still healthy but aging.
The Muscle Connection: Why Sarcopenia and Cognitive Decline Are the Same Problem
A companion paper from the same CABA trial, published in Frontiers in Nutrition in September 2025, examined what creatine did to muscle in these Alzheimer's patients — and found equally surprising results.
After 8 weeks of supplementation, participants showed:
- A 1.9 kg (~6%) increase in handgrip strength
- Statistically significant increases in muscle cross-sectional area in the rectus femoris and vastus medialis (two major leg muscles)
- Decreases in subcutaneous fat around the leg muscles
This matters because sarcopenia — age-related muscle loss — is directly linked to Alzheimer's risk. A 2021 study in the Journal of the American Geriatrics Society found that sarcopenia is associated with significantly higher rates of incident Alzheimer's dementia and cognitive decline. The muscle-brain connection runs deeper than most people realize.
Here's the mechanism researchers have uncovered: muscle tissue releases signaling molecules called myokines when it contracts. These myokines travel to the brain and support neurogenesis, reduce inflammation, and protect neurons. When muscle mass declines with age, this protective signaling diminishes. The brain loses a key source of biological support — and vulnerability to Alzheimer's increases.
Creatine addresses both sides of this equation simultaneously. It helps preserve muscle mass (and the myokine signaling that comes with it) while also directly increasing energy availability in the brain. That's a genuinely rare combination for any single intervention.
What a May 2026 Scientific Review Adds to the Picture
Just days ago, ScienceDaily published coverage of Dr. Mehdi Boroujerdi's comprehensive review of creatine biology, published in the Handbook of Creatine and Creatinine In Vivo Kinetics (CRC Press, May 2026). The review synthesizes decades of creatine research and arrives at a striking conclusion:
"With sufficient justification, appropriate dosage form, and dosing regimen, creatine may eventually be recognized as an over-the-counter therapeutic agent rather than merely a dietary supplement," Boroujerdi wrote.
The review also highlights two groups who may benefit most from creatine supplementation: older adults (who typically have lower baseline creatine stores and experience greater relative improvements) and women (who often have naturally lower stored creatine than men and may see proportionally larger gains from supplementation).
This aligns with growing evidence that creatine's brain benefits are most pronounced in people with lower baseline levels — which is precisely the situation most adults find themselves in after 40, as the body's natural creatine synthesis declines with age.
How the Brain's Energy System Breaks Down After 40 — and How to Protect It
Between the ages of 40 and 70, several things happen to the brain's energy metabolism:
- Mitochondrial efficiency declines. The organelles that produce ATP become less effective, generating less energy per unit of oxygen consumed.
- Brain creatine concentrations drop. Studies using MRS imaging show measurable decreases in brain phosphocreatine as people age.
- Oxidative stress accumulates. The brain's antioxidant defenses weaken, allowing free radicals to damage neurons and their energy-producing machinery.
- Glucose metabolism slows. The brain becomes less efficient at extracting energy from glucose — a phenomenon now recognized as a preclinical marker of Alzheimer's risk.
Creatine supplementation works against all four of these processes. It directly replenishes phosphocreatine stores, supports mitochondrial function, exerts antioxidant effects (creatine has documented free radical-scavenging properties), and provides an alternative energy pathway that doesn't depend solely on glucose metabolism.
One supplement gaining serious research attention for this exact constellation of aging-related brain changes is creatine monohydrate. A 2025 systematic review in Nutrition Reviews examining creatine and cognition in generally healthy older adults found evidence of "favorable" cognitive effects. While the authors noted that more large-scale trials are needed, the mechanistic case for early supplementation in adults over 40 is increasingly compelling.
🧪 ATO Health Creatine — Formulated for Adults Over 40
Micronized creatine monohydrate. No fillers, no creatine HCl gimmicks — just the form backed by 200+ studies and the exact compound used in the CABA Alzheimer's trial.
What This Means For You: Practical Action Steps
The CABA trial used 20 grams per day specifically to maximize brain delivery — a higher dose was chosen because creatine is preferentially taken up by muscle tissue, so getting meaningful amounts to the brain typically requires higher doses or longer supplementation periods. However, for healthy adults using creatine as a preventive measure, standard dosing is appropriate.
Standard maintenance dose: 3–5 grams of creatine monohydrate daily. This amount has been shown in decades of research to saturate muscle creatine stores over approximately 28 days, with measurable effects on brain creatine levels in regular users.
Loading phase (optional): 20 grams per day (split into 4 doses) for 5–7 days, followed by 3–5 grams daily. This saturates stores faster and may be especially relevant for older adults who want quicker results.
Form matters: Use creatine monohydrate — the exact form used in every major study, including CABA. Creatine HCl and other variants are more expensive and have no demonstrated superiority in research.
Pair with resistance training: The muscle-brain connection means that building and maintaining muscle through strength training amplifies creatine's brain-protective effects. The two work synergistically — not independently.
Consistency is the key variable: The CABA study saw 11% brain creatine increases in 8 weeks. Longer-term consistent supplementation is likely to produce larger and more sustained effects. This isn't a short-term intervention — it's a long-term protective strategy.
Frequently Asked Questions
Q: Can creatine actually prevent Alzheimer's disease?
A: No supplement has been proven to prevent Alzheimer's disease, and creatine is no exception. What the CABA study showed is that creatine can increase brain energy levels and produce modest cognitive improvements in people who already have Alzheimer's. For healthy adults, the rationale for creatine is preventive — supporting the brain energy systems that may be compromised decades before symptoms appear. It is one of several evidence-based strategies (alongside exercise, sleep, and diet) that may help maintain cognitive health as you age.
Q: What dose of creatine should adults over 40 take for brain health?
A: The standard maintenance dose studied for brain benefits in healthy older adults is 3–5 grams of creatine monohydrate per day. The CABA Alzheimer's trial used 20 grams per day (in two 10g doses) to overcome muscle uptake and get creatine to the brain more quickly. For prevention, 5 grams daily taken consistently over months is the most practical and well-supported approach for healthy adults over 40.
Q: Is creatine safe for people over 40 to take long-term?
A: Yes — creatine monohydrate is one of the most extensively studied dietary supplements available, with hundreds of clinical trials documenting its safety in healthy adults. Long-term supplementation at 3–5 grams per day has not been associated with kidney damage, liver damage, or other adverse effects in people with normal kidney function. Individuals with pre-existing kidney disease should consult a doctor before supplementing.
Q: How does creatine improve memory and cognitive function?
A: Creatine is stored in the brain as phosphocreatine, which rapidly regenerates ATP when neurons need energy. The brain consumes approximately 20% of the body's total energy despite being only 2% of body weight. When brain phosphocreatine stores are replenished through supplementation, neurons have faster access to energy for signaling, memory consolidation, and synaptic maintenance. Studies using brain imaging have confirmed that oral creatine supplementation measurably increases brain creatine concentrations — and the CABA trial showed this even in Alzheimer's patients.
Q: Why is muscle loss after 40 connected to Alzheimer's risk?
A: Muscle tissue is not passive storage — it's an active endocrine organ that releases signaling molecules called myokines during exercise and contraction. These myokines cross the blood-brain barrier and support neurogenesis, reduce neuroinflammation, and promote the survival of neurons. When muscle mass declines with age (sarcopenia), this protective signaling diminishes. Multiple studies have found that low muscle mass is independently associated with higher risk of Alzheimer's dementia and faster cognitive decline. Creatine helps preserve both muscle and brain by supporting energy metabolism in both tissues simultaneously.
Q: Is creatine monohydrate the right form, or should I use creatine HCl?
A: Creatine monohydrate is the correct form — it's the compound used in virtually every human study of creatine's effects on muscle, brain, and disease, including the CABA Alzheimer's trial. Creatine HCl is more expensive and claims to be more soluble, but no peer-reviewed research demonstrates superior efficacy for brain or muscle outcomes compared to monohydrate. Choose micronized creatine monohydrate for best mixability.
Sources & Further Reading
- Smith AN, Choi IY, Lee P, et al. "Creatine monohydrate pilot in Alzheimer's: feasibility, brain creatine, and cognition." Alzheimer's & Dementia: Translational Research & Clinical Interventions. (2025). doi: 10.1002/trc2.70101
- Smith AN, Sullivan DK, Morris JK, et al. "Eight weeks of creatine monohydrate supplementation is associated with increased muscle strength and size in Alzheimer's disease." Frontiers in Nutrition. (September 2025). doi: 10.3389/fnut.2025.1670641
- Boroujerdi M. Handbook of Creatine and Creatinine In Vivo Kinetics: Production, Distribution, Metabolism, and Excretion. CRC Press. (May 2026). doi: 10.1201/9781003604662
- Beeri MS, Leugrans SE, Delbono O, et al. "Sarcopenia is associated with incident Alzheimer's dementia, mild cognitive impairment, and cognitive decline." Journal of the American Geriatrics Society. (2021). doi: 10.1111/jgs.17206
- Prokopidis K, Giannos P, Triantafyllidis KK, et al. "Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials." Nutrition Reviews. (2023) 81:1497–1500.
- ScienceDaily. "Scientists reveal creatine's hidden power beyond muscle gains." Taylor & Francis Group. May 4, 2026. sciencedaily.com/releases/2026/05/260504023828.htm
- KU Medical Center. "Creatine shows potential to boost cognition in Alzheimer's patients." June 4, 2025. kumc.edu/about/news/news-archive/creatine-alzheimers-research.html